Situation: A 34-year-old man is admitted with newly diagnosed acute myeloid leukemia (AML). His white blood cell count is 45,000/mm³ with 70% blasts, his hemoglobin is 8.2 g/dL (82 g/L), and his platelet count is 15,000/mm³. Induction chemotherapy is planned. His wife asks why he keeps getting infections when his white blood cell count is so high. Which explanation is accurate?

In acute leukemia, malignant precursors (blasts) multiply in the marrow and spill into the blood, so the total count may be high. Blasts are immature and do not function as neutrophils, and they crowd out normal marrow cells. The result is functional neutropenia, with infection as the leading cause of death.

Why a high WBC count does not mean better infection defense in AML

In acute myeloid leukemia, the bone marrow is overtaken by malignant precursor cells called blasts. These blasts multiply rapidly and spill into the peripheral blood, which is why the total white blood cell count can appear dramatically elevated—here, 45,000/mm³ with 70% blasts. However, the key point is that blasts are functionally useless for fighting infection because they are immature cells that have not developed into working neutrophils.

The absolute neutrophil count (ANC), not the total WBC count, determines the patient’s real capacity to combat bacteria and fungi. In this patient, the marrow is so crowded with leukemic blasts that normal hematopoietic precursors are suppressed—a phenomenon often described as “crowding out.” As a result, the production of mature, segmented neutrophils falls dramatically. The patient therefore has functional neutropenia despite a high total white count, because the vast majority of circulating white cells are blasts that cannot phagocytose, generate respiratory burst, or migrate to sites of infection.

Watch out! Do not equate a high total WBC count with immune competence. In acute leukemia, the total count can be misleadingly high while the ANC is critically low. The infection risk tracks with the ANC, not the total WBC.

Key point! Infection is the leading cause of death in acute leukemia, driven by functional neutropenia from blast crowding and impaired normal marrow production.

The distinction between total WBC count and functional neutrophil capacity is central to understanding why this patient “keeps getting infections.” Neutropenia is defined by a reduction in the absolute number of circulating neutrophils, and when it arises from an underlying hematologic malignancy such as AML, the risk of infectious complications is substantial ^[1]. In leukemia, malignant hematopoiesis disrupts normal immune effector cell production, and intensive chemotherapy further depletes functional neutrophils, compounding the infection risk ^[3]. The disruption of normal hematopoietic homeostasis in leukemia also alters host-microbiome interactions, which can impair barrier function and shift immune responses in ways that further increase susceptibility to infection .

Parameter	This patient	Clinical meaning
Total WBC count	45,000/mm³	High due to circulating blasts; not protective
Blast percentage	70%	Immature, nonfunctional leukemic cells
Functional neutrophils (ANC)	Critically low (not directly given)	Determines true infection risk
Hemoglobin	8.2 g/dL (82 g/L)	Anemia from marrow crowding
Platelets	15,000/mm³	Severe thrombocytopenia; bleeding risk

The other answer choices do not explain the recurrent infections. The spleen does not selectively trap white cells before they reach tissues in AML. Antibodies are not “used up” by a high white cell count. And while leukemic blasts do crowd out normal marrow cells, they do not directly attack and destroy mature neutrophils in the circulation—the problem is failed production of functional cells, not active destruction of normal white cells. The accurate explanation is that most of the circulating white cells are immature blasts that cannot fight germs, leaving the patient functionally neutropenic and highly vulnerable to infection.